A family's search for others with Nicolaides-Baraitser syndrome illuminates the ultra-rare disease experience

STAT News profiles a mother and daughter's years-long effort to connect with other families affected by Nicolaides-Baraitser syndrome, an ultra-rare genetic neurodevelopmental condition.

Published · AI-drafted summary based on 1 public source
Illustration for rare disease story
Illustrative image — not from the source article.
Share

A long-read feature published by STAT News recounts the experiences of a family navigating a diagnosis of Nicolaides-Baraitser syndrome (NCBRS), an ultra-rare neurodevelopmental disorder caused by pathogenic variants in the SMARCA2 gene, which encodes a component of the SWI/SNF chromatin-remodelling complex. The piece, written from the perspective of a family member, describes the years that elapsed between a paediatric geneticist's warning not to search online and the family's eventual decision to engage with the broader NCBRS community.

The feature touches on themes familiar to families with rare genetic diagnoses: diagnostic odyssey, the isolation of conditions with small patient populations, the role of family-led registries and patient advocacy groups in connecting affected individuals, and the emotional weight of receiving a genetic diagnosis with limited natural history data.

Nicolaides-Baraitser syndrome is characterised by intellectual disability, limited speech, behavioural features, and distinctive facial features. Fewer than several hundred cases have been described in the published literature, making it representative of a broad category of Mendelian neurodevelopmental conditions where research progress depends heavily on international collaboration and family participation in registries.

The piece is an editorial/personal narrative rather than a primary research report, but it offers perspectives of direct relevance to genetic counsellors, educators working on rare disease communication, and patients and families encountering similar situations.

Plain-language version

For patients, families, and general readers. Educational only — not medical advice.

Nicolaides-Baraitser syndrome is an extremely rare condition caused by changes in a single gene called SMARCA2. This gene helps control how DNA is packaged inside cells. People with the condition often have learning difficulties, limited speech, and other features that vary between individuals.

Because so few people in the world have this diagnosis, families can feel very isolated. The STAT News article describes one family's journey — from receiving the diagnosis to eventually finding and connecting with others living with the same condition. Their story highlights how patient communities, online registries, and advocacy groups can bring families together when a condition is too rare for most doctors to have seen more than one or two cases.

Researchers and clinicians studying ultra-rare conditions often rely on families sharing their experiences and participating in international registries. These contributions help build the natural history data that future research depends on.

This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source Stat News · 2026-10-08
    A mother-daughter quest to find fellow members of an ultra-rare genetic community

Tags

nicolaides-baraitser-syndrome smarca2 rare-disease neurodevelopmental-disorders patient-advocacy diagnostic-odyssey rare-disease-community
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List